Zobrazeno 1 - 10
of 111
pro vyhledávání: '"M. Kosmin"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Radiotherapy and Oncology. 170:S201-S202
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e06f909406af20e001d664515bf99622
https://doi.org/10.1016/s0167-8140(22)02795-5
https://doi.org/10.1016/s0167-8140(22)02795-5
Publikováno v:
Radiotherapy and Oncology. 170:S207-S208
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bef57790930fa33df99608949550bee6
https://doi.org/10.1016/s0167-8140(22)02800-6
https://doi.org/10.1016/s0167-8140(22)02800-6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S. Moinuddin, Cian Hughes, M. Kosmin, Alan Karthikesalingam, Bernardino Romera-Paredes, D. de Souza, L. Gunn, Joseph R. Ledsam, Christopher Kelly, Christopher M. Nutting, Ricky A. Sharma, R. Mendes
Publikováno v:
Radiotherapy and Oncology. 135:130-140
Advances in technical radiotherapy have resulted in significant sparing of organs at risk (OARs), reducing radiation-related toxicities for patients with cancer of the head and neck (HNC). Accurate delineation of target volumes (TVs) and OARs is crit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a9b454054362e07c76607c95e88651a
https://doi.org/10.1016/j.radonc.2019.03.004
https://doi.org/10.1016/j.radonc.2019.03.004
Autor:
Dow-Mu Koh, Stephanie Sutherland, Mei-Lin Ah-See, Anwar R. Padhani, Peter Ostler, M. Kosmin, Andrea Marshall, Janet A. Dunn, David Woolf, Andrew Gogbashian, Jillian Noble, David Miles, Andreas Makris
In participants receiving systemic anticancer therapy for bone-only metastatic breast cancer, whole-body MRI enabled identification of progressive disease earlier than whole-body CT and bone scintigraphy.\ud \ud Background\ud CT and bone scintigraphy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b65c878f9a3d0dafdde59c9433004d98
http://wrap.warwick.ac.uk/143637/1/WRAP-Comparison-whole-body-MRI-CT-bone-Marshall-2020.pdf
http://wrap.warwick.ac.uk/143637/1/WRAP-Comparison-whole-body-MRI-CT-bone-Marshall-2020.pdf
Publikováno v:
Radiotherapy and Oncology. 161:S786
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c1bca6a35d08c02ab069bda50f3fbc8
https://doi.org/10.1016/s0167-8140(21)07222-4
https://doi.org/10.1016/s0167-8140(21)07222-4
Publikováno v:
Cancer Research. 77:P4-21
Introduction Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate used for treatment of human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer. An association between T-DM1 and splenic enlargement was noted anecdotal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b27bcab8676cb44ebcbcee5da33486dd
https://doi.org/10.1158/1538-7445.sabcs16-p4-21-36
https://doi.org/10.1158/1538-7445.sabcs16-p4-21-36
Publikováno v:
Targeted Oncology. 12:229-234
An association between trastuzumab-emtansine (T-DM1) and splenic enlargement is reported in preclinical data, and has been noted anecdotally in patients receiving T-DM1 at our institution. Use of whole-body MRI examinations (WB-MRI) allows for detail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a26143c19d31de2d0eb4a29989e122
https://doi.org/10.1007/s11523-017-0477-6
https://doi.org/10.1007/s11523-017-0477-6
Autor:
M. Kosmin, Andrew Gvozdanovic, Andy McEvoy, Rayna Patel, Georgina Kirby, Riccardo Mangiapelo, Hani J. Marcus, Naomi Fersht, Neil Kitchen, Norman R. Williams, Anna Miserocchi, Patrick J Grover, Lewis Thorne
Publikováno v:
Journal of Clinical Oncology. 39:e13582-e13582
e13582 Background: Cancers of the brain lead to significant neurocognitive, physical and psychological morbidities. Digital technologies provide a novel platform to capture and evaluate these needs. Mobile health (mHealth) applications typically focu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::060d01d048871554b25d89dbcb00bc88
https://doi.org/10.1200/jco.2021.39.15_suppl.e13582
https://doi.org/10.1200/jco.2021.39.15_suppl.e13582